Faced with the requirements of Good Manufacturing Practice, and operating under The Medicines Act, the pharmaceutical industry can benefit from using robots and robotic devices to manage and improve quality and containment in pharmaceutical development and manufacture.

Moreover, CSR E-Hub can assist in introducing new ways of working by producing accurate simulations of processes which may have never been envisaged or tested before. However, there has to be a confidence building stage as novel cells are set up to test out a new way of working. It is here that CSR E-Hub can again make a dramatic impact - first by helping the engineers to appreciate the advantages and (possibly) the problems of adopting a robotic solution, and secondly by providing some accurate information as to whether the planned sequence will be accurate and practical. If not then further ‘what if scenario’ simulations can be run to improve the results. Finally, CSR E-Hub, in addition to the simulation with its visual output, can give good guidance on timings for the various operations. As usual, with all simulations, the extra confidence of a highly visual method encourages engineers to try out new schemes and scenarios, which would not otherwise have been possible.

For further information on CSR E-Hub in pharmaceutical processing and medical equipment manufacture contact us.